Last updated: October 10, 2023
Sponsor: Hamad Medical Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Traumatic Brain Injury
Memory Loss
Dementia
Treatment
technology based intervention along with conventional therapy
conventional therapy alone
Clinical Study ID
NCT06080269
MRC-01-21-857
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects with traumatic brain injury i.e damage to the brain resulting from externalmechanical force, such as rapid acceleration or deceleration, impact, blast waves, orpenetration by a projectile
- Adults aged between 18 and 60 years old
- No previous history of head trauma
- With MMSE score >10 and < 23 (people with mild to moderate cognitive deficit)
- Ability to give consent and willingness to comply with cognitive rehabilitationprogram.
Exclusion
Exclusion Criteria:
- Pre-existing chronic illness that causes neurological symptoms or complications suchas congenital disorder, history of stroke, tumor, brain infection or any otherprevious disorder due to brain damage affecting the cognition.
- History of any psychiatry disorders which affects the cognitive functions such asschizophrenia, bipolar disorder etc.
- Those who cannot follow basic simple instruction or comprehend simple commands
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: technology based intervention along with conventional therapy
Phase:
Study Start date:
May 25, 2022
Estimated Completion Date:
December 30, 2024
Study Description
Connect with a study center
Qatar Rehabilitation Institute, Hamad Medical Corporation
Doha, 3050
QatarActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.